LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,089
تعداد مقالات9,995
تعداد مشاهده مقاله26,328,403
تعداد دریافت فایل اصل مقاله7,272,363
Soltani, Saber, Zandi, Milad, Ahmadi, Seyed-Esmaeil, Zarandi, Bahman, Hosseini, Zeinab, Akhavan Rezayat, Sara, Abyadeh, Morteza, Pakzad, Iraj, Malekifar, Pooneh, Pakzad, Reza, Mozhgani, Sayed-Hamidreza. (1400). Pooled Prevalence Estimate of Ocular Manifestations in COVID-19 Patients: A Systematic Review and Meta-Analysis. سامانه مدیریت نشریات علمی, 47(1), 2-14. doi: 10.30476/ijms.2021.89475.2026
Saber Soltani; Milad Zandi; Seyed-Esmaeil Ahmadi; Bahman Zarandi; Zeinab Hosseini; Sara Akhavan Rezayat; Morteza Abyadeh; Iraj Pakzad; Pooneh Malekifar; Reza Pakzad; Sayed-Hamidreza Mozhgani. "Pooled Prevalence Estimate of Ocular Manifestations in COVID-19 Patients: A Systematic Review and Meta-Analysis". سامانه مدیریت نشریات علمی, 47, 1, 1400, 2-14. doi: 10.30476/ijms.2021.89475.2026
Soltani, Saber, Zandi, Milad, Ahmadi, Seyed-Esmaeil, Zarandi, Bahman, Hosseini, Zeinab, Akhavan Rezayat, Sara, Abyadeh, Morteza, Pakzad, Iraj, Malekifar, Pooneh, Pakzad, Reza, Mozhgani, Sayed-Hamidreza. (1400). 'Pooled Prevalence Estimate of Ocular Manifestations in COVID-19 Patients: A Systematic Review and Meta-Analysis', سامانه مدیریت نشریات علمی, 47(1), pp. 2-14. doi: 10.30476/ijms.2021.89475.2026
Soltani, Saber, Zandi, Milad, Ahmadi, Seyed-Esmaeil, Zarandi, Bahman, Hosseini, Zeinab, Akhavan Rezayat, Sara, Abyadeh, Morteza, Pakzad, Iraj, Malekifar, Pooneh, Pakzad, Reza, Mozhgani, Sayed-Hamidreza. Pooled Prevalence Estimate of Ocular Manifestations in COVID-19 Patients: A Systematic Review and Meta-Analysis. سامانه مدیریت نشریات علمی, 1400; 47(1): 2-14. doi: 10.30476/ijms.2021.89475.2026

Pooled Prevalence Estimate of Ocular Manifestations in COVID-19 Patients: A Systematic Review and Meta-Analysis

Iranian Journal of Medical Sciences
مقاله 2، دوره 47، شماره 1، فروردین 2022، صفحه 2-14    اصل مقاله (1.13 M)
نوع مقاله: Review Article
شناسه دیجیتال (DOI): 10.30476/ijms.2021.89475.2026
نویسندگان
Saber Soltani1، 2؛ Milad Zandi3، 4؛ Seyed-Esmaeil Ahmadi3؛ Bahman Zarandi3؛ Zeinab Hosseini4؛ Sara Akhavan Rezayat5؛ Morteza Abyadeh6؛ Iraj Pakzad7، 8؛ Pooneh Malekifar9؛ Reza Pakzad* 10، 11؛ Sayed-Hamidreza Mozhgani12، 13
1Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
2Research Center for Clinical Virology, Department of Virology, Tehran University of Medical Sciences, Tehran, Iran
3Department of Hematology and Blood Banking, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
4Hepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
5Department of Health Economics and Management, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
6Cell Science Research Center, Department of Molecular Systems Biology, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
7Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran
8Department of Microbiology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran
9Department of Epidemiology, School of Public Health, Tehran University Medical Sciences, Tehran, Iran
10Department of Epidemiology, Faculty of Health, Ilam University Medical Sciences, Ilam, Iran
11Noor Research Center for Ophthalmic Epidemiology, Noor Eye Hospital, Tehran, Iran
12Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
13Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
چکیده
Background: There are reports of ocular tropism due to respiratory viruses such as severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Various studies have shown ocular manifestation in coronavirus disease-2019 (COVID-19) patients. We aimed to identify ophthalmic manifestations in COVID-19 patients and establish an association between ocular symptoms and SARS-CoV-2 infection.
Methods: A systematic search of Medline, Scopus, Web of Science, Embase, and Cochrane Library was conducted for publications from December 2019 to April 2021. The search included MeSH terms such as SARS-CoV-2 and ocular manifestations. The pooled prevalence estimate (PPE) with 95% confidence interval (CI) was calculated using binomial distribution and random effects. The meta-regression method was used to examine factors affecting heterogeneity between studies.
Results: Of the 412 retrieved articles, 23 studies with a total of 3,650 COVID-19 patients were analyzed. The PPE for any ocular manifestations was 23.77% (95% CI: 15.73-31.81). The most prevalent symptom was dry eyes with a PPE of 13.66% (95% CI: 5.01-25.51). The PPE with 95% CI for conjunctival hyperemia, conjunctival congestion/conjunctivitis, and ocular pain was 13.41% (4.65-25.51), 9.14% (6.13-12.15), and 10.34% (4.90-15.78), respectively. Only two studies reported ocular discomfort and diplopia. The results of meta-regression analysis showed that age and sample size had no significant effect on the prevalence of any ocular manifestations. There was no significant publication bias in our meta-analysis.
Conclusion: There is a high prevalence of ocular manifestations in COVID-19 patients. The most common symptoms are dry eyes, conjunctival hyperemia, conjunctival congestion/conjunctivitis, ocular pain, irritation/itching/burning sensation, and foreign body sensation.
کلیدواژه‌ها
COVID-19؛ SARS-CoV-2؛ Eye manifestations؛ Systematic review؛ Meta-analysis
سایر فایل های مرتبط با مقاله
مراجع
  1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20. doi: 10.1056/NEJMoa2002032. PubMed PMID: 32109013; PubMed Central PMCID: PMCPMC7092819.
  2. World Health Organization [Internet]. Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update. [Accessed: November 25, 2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
  3. Soltani S. The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43. Eur Rev Med Pharmacol Sci. 2020;24:6484-5. doi: 10.26355/eurrev_202006_21630. PubMed PMID: 32633334.
  4. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382:1199-207. doi: 10.1056/NEJMoa2001316. PubMed PMID: 31995857; PubMed Central PMCID: PMCPMC7121484.
  5. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420-2. doi: 10.1016/S2213-2600(20)30076-X. PubMed PMID: 32085846; PubMed Central PMCID: PMCPMC7164771.
  6. Fani M, Zandi M, Soltani S, Abbasi S. Future developments in biosensors for field-ready SARS-CoV-2 virus diagnostics. Biotechnol Appl Biochem. 2021;68:695-9. doi: 10.1002/bab.2033. PubMed PMID: 32970352; PubMed Central PMCID: PMCPMC7537309.
  7. Soltani S, Tabibzadeh A, Zakeri A, Zakeri AM, Latifi T, Shabani M, et al. COVID-19 associated central nervous system manifestations, mental and neurological symptoms: a systematic review and meta-analysis. Rev Neurosci. 2021;32:351-61. doi: 10.1515/revneuro-2020-0108. PubMed PMID: 33618441.
  8. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061-9. doi: 10.1001/jama.2020.1585. PubMed PMID: 32031570; PubMed Central PMCID: PMCPMC7042881.
  9. Lee YH, Kim YC, Shin JP. Characteristics of Ocular Manifestations of Patients with Coronavirus Disease 2019 in Daegu Province, Korea. J Korean Med Sci. 2020;35:e322. doi: 10.3346/jkms.2020.35.e322. PubMed PMID: 32893523; PubMed Central PMCID: PMCPMC7476796.
  10. Abrishami M, Tohidinezhad F, Daneshvar R, Omidtabrizi A, Amini M, Sedaghat A, et al. Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran. Ocul Immunol Inflamm. 2020;28:739-44. doi: 10.1080/09273948.2020.1773868. PubMed PMID: 32569494.
  11. Zhang X, Chen X, Chen L, Deng C, Zou X, Liu W, et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf. 2020;18:360-2. doi: 10.1016/j.jtos.2020.03.010. PubMed PMID: 32289466; PubMed Central PMCID: PMCPMC7194535.
  12. Ma D, Chen CB, Jhanji V, Xu C, Yuan XL, Liang JJ, et al. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye (Lond). 2020;34:1212-9. doi: 10.1038/s41433-020-0939-4. PubMed PMID: 32382146; PubMed Central PMCID: PMCPMC7205026.
  13. Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395:e39. doi: 10.1016/S0140-6736(20)30313-5. PubMed PMID: 32035510; PubMed Central PMCID: PMCPMC7133551.
  14. Zhou Y, Duan C, Zeng Y, Tong Y, Nie Y, Yang Y, et al. Ocular Findings and Proportion with Conjunctival SARS-COV-2 in COVID-19 Patients. Ophthalmology. 2020;127:982-3. doi: 10.1016/j.ophtha.2020.04.028. PubMed PMID: 32359840; PubMed Central PMCID: PMCPMC7194804.
  15. Atum M, Boz AAE, Cakir B, Karabay O, Koroglu M, Ogutlu A, et al. Evaluation of Conjunctival Swab PCR Results in Patients with SARS-CoV-2 Infection. Ocul Immunol Inflamm. 2020;28:745-8. doi: 10.1080/09273948.2020.1775261. PubMed PMID: 32569495.
  16. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097. PubMed PMID: 19621072; PubMed Central PMCID: PMCPMC2707599.
  17. Liu WR, Zuo GJ, Qin Y. Clinical characteristics and outcomes of 2019-nCoV-infected patients admitted at different time periods. Eur Rev Med Pharmacol Sci. 2020;24:7826-33. doi: 10.26355/eurrev_202007_22287. PubMed PMID: 32744710.
  18. Sindhuja K, Lomi N, Asif MI, Tandon R. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study. Indian J Ophthalmol. 2020;68:1546-50. doi: 10.4103/ijo.IJO_1319_20. PubMed PMID: 32709772; PubMed Central PMCID: PMCPMC7640841.
  19. Guemes-Villahoz N, Burgos-Blasco B, Arribi-Vilela A, Arriola-Villalobos P, Rico-Luna CM, Cuina-Sardina R, et al. Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19? J Med Virol. 2021;93:383-8. doi: 10.1002/jmv.26219. PubMed PMID: 32579256; PubMed Central PMCID: PMCPMC7361904.
  20. Guemes-Villahoz N, Burgos-Blasco B, Garcia-Feijoo J, Saenz-Frances F, Arriola-Villalobos P, Martinez-de-la-Casa JM, et al. Conjunctivitis in COVID-19 patients: frequency and clinical presentation. Graefes Arch Clin Exp Ophthalmol. 2020;258:2501-7. doi: 10.1007/s00417-020-04916-0. PubMed PMID: 32860573; PubMed Central PMCID: PMCPMC7455778.
  21. Karimi S, Arabi A, Shahraki T, Safi S. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019. Eye (Lond). 2020;34:1220-3. doi: 10.1038/s41433-020-0965-2. PubMed PMID: 32424329; PubMed Central PMCID: PMCPMC7232592.
  22. Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol. 2020;98:e649-e55. doi: 10.1111/aos.14445. PubMed PMID: 32336042; PubMed Central PMCID: PMCPMC7267628.
  23. Rokohl AC, Loreck N, Wawer Matos PA, Zwingelberg S, Augustin M, Dewald F, et al. More than loss of taste and smell: burning watering eyes in coronavirus disease 2019. Clin Microbiol Infect. 2020;26:1560. doi: 10.1016/j.cmi.2020.08.018. PubMed PMID: 32835793; PubMed Central PMCID: PMCPMC7442009.
  24. Cavalleri M, Brambati M, Starace V, Capone L, Nadin F, Pederzolli M, et al. Ocular Features and Associated Systemic Findings in SARS-CoV-2 Infection. Ocul Immunol Inflamm. 2020;28:916-21. doi: 10.1080/09273948.2020.1781198. PubMed PMID: 32870738.
  25. Oncul H, Oncul FY, Alakus MF, Caglayan M, Dag U. Ocular findings in patients with coronavirus disease 2019 (COVID-19) in an outbreak hospital. J Med Virol. 2021;93:1126-32. doi: 10.1002/jmv.26412. PubMed PMID: 32776614; PubMed Central PMCID: PMCPMC7436579.
  26. Chen L, Deng C, Chen X, Zhang X, Chen B, Yu H, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020;98:e951-e9. doi: 10.1111/aos.14472. PubMed PMID: 32421258; PubMed Central PMCID: PMCPMC7276826.
  27. Valente P, Iarossi G, Federici M, Petroni S, Palma P, Cotugno N, et al. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report. J AAPOS. 2020;24:212-5. doi: 10.1016/j.jaapos.2020.05.002. PubMed PMID: 32531341; PubMed Central PMCID: PMCPMC7282793.
  28. Bostanci Ceran B, Ozates S. Ocular manifestations of coronavirus disease 2019. Graefes Arch Clin Exp Ophthalmol. 2020;258:1959-63. doi: 10.1007/s00417-020-04777-7. PubMed PMID: 32504100; PubMed Central PMCID: PMCPMC7274940.
  29. Invernizzi A, Torre A, Parrulli S, Zicarelli F, Schiuma M, Colombo V, et al. Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine. 2020;27:100550. doi: 10.1016/j.eclinm.2020.100550. PubMed PMID: 32984785; PubMed Central PMCID: PMCPMC7502280.
  30. Tostmann A, Bradley J, Bousema T, Yiek WK, Holwerda M, Bleeker-Rovers C, et al. Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020. Euro Surveill. 2020;25. doi: 10.2807/1560-7917.ES.2020.25.16.2000508. PubMed PMID: 32347200; PubMed Central PMCID: PMCPMC7189649.
  31. Bourdon H, Jaillant R, Ballino A, El Kaim P, Debillon L, Bodin S, et al. Teleconsultation in primary ophthalmic emergencies during the COVID-19 lockdown in Paris: Experience with 500 patients in March and April 2020. J Fr Ophtalmol. 2020;43:577-85. doi: 10.1016/j.jfo.2020.05.005. PubMed PMID: 32564983; PubMed Central PMCID: PMCPMC7284250.
  32. Xu L, Zhang X, Song W, Sun B, Mu J, Wang B, et al. Conjunctival polymerase chain reaction-tests of 2019 novel coronavirus in patients in Shenyang, China. 2021;2:15-20. doi: 10.46766/thegms.ophthal.21011001.
  33. Lan QQ, Zeng SM, Liao X, Xu F, Qi H, Li M. [A special on epidemic prevention and control:screening for novel coronavirus related conjunctivitis among the patients with coronavirus disease 2019]. Zhonghua Yan Ke Za Zhi. 2020;56:433-7. doi: 10.3760/cma.j.cn112142-20200322-00213. PubMed PMID: 32295324.
  34. Perlman A, Vodonos Zilberg A, Bak P, Dreyfuss M, Leventer-Roberts M, Vurembrand Y, et al. Characteristics and Symptoms of App Users Seeking COVID-19-Related Digital Health Information and Remote Services: Retrospective Cohort Study. J Med Internet Res. 2020;22:e23197. doi: 10.2196/23197. PubMed PMID: 32961527; PubMed Central PMCID: PMCPMC7609191.
  35. Aggarwal K, Agarwal A, Jaiswal N, Dahiya N, Ahuja A, Mahajan S, et al. Ocular surface manifestations of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. PLoS One. 2020;15:e0241661. doi: 10.1371/journal.pone.0241661. PubMed PMID: 33151999; PubMed Central PMCID: PMCPMC7643964.
  36. Cheong KX. Systematic Review of Ocular Involvement of SARS-CoV-2 in Coronavirus Disease 2019. Curr Ophthalmol Rep. 2020:1-10. doi: 10.1007/s40135-020-00257-7. PubMed PMID: 33014631; PubMed Central PMCID: PMCPMC7519854.
  37. Nasiri N, Sharifi H, Bazrafshan A, Noori A, Karamouzian M, Sharifi A. Ocular Manifestations of COVID-19: A Systematic Review and Meta-analysis. J Ophthalmic Vis Res. 2021;16:103-12. doi: 10.18502/jovr.v16i1.8256. PubMed PMID: 33520133; PubMed Central PMCID: PMCPMC7841281.
  38. Inomata T, Kitazawa K, Kuno T, Sung J, Nakamura M, Iwagami M, et al. Clinical and Prodromal Ocular Symptoms in Coronavirus Disease: A Systematic Review and Meta-Analysis. Invest Ophthalmol Vis Sci. 2020;61:29. doi: 10.1167/iovs.61.10.29. PubMed PMID: 32797198; PubMed Central PMCID: PMCPMC7441339.
  39. Perez Alvarez AI, Suarez Cuervo C, Fernandez Menendez S. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies. Neurologia (Engl Ed). 2020;35:264-5. doi: 10.1016/j.nrl.2020.04.003. PubMed PMID: 32364121; PubMed Central PMCID: PMCPMC7165292.
  40. Falcone MM, Rong AJ, Salazar H, Redick DW, Falcone S, Cavuoto KM. Acute abducens nerve palsy in a patient with the novel coronavirus disease (COVID-19). J AAPOS. 2020;24:216-7. doi: 10.1016/j.jaapos.2020.06.001. PubMed PMID: 32592761; PubMed Central PMCID: PMCPMC7311910.
  41. Belghmaidi S, Nassih H, Boutgayout S, El Fakiri K, El Qadiry R, Hajji I, et al. Third Cranial Nerve Palsy Presenting with Unilateral Diplopia and Strabismus in a 24-Year-Old Woman with COVID-19. Am J Case Rep. 2020;21:e925897. doi: 10.12659/AJCR.925897. PubMed PMID: 33056942; PubMed Central PMCID: PMCPMC7571280.
  42. Schwarz L, Lwowski C, Schmack I, Muller M, Adam E, Zacharowski K, et al. [Ophthalmological care of SARS-CoV-2 positive patients in intensive care units]. Ophthalmologe. 2020;117:602-8. doi: 10.1007/s00347-020-01159-6. PubMed PMID: 32617666; PubMed Central PMCID: PMCPMC7331495.
  43. Zhou L, Xu Z, Castiglione GM, Soiberman US, Eberhart CG, Duh EJ. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocul Surf. 2020;18:537-44. doi: 10.1016/j.jtos.2020.06.007. PubMed PMID: 32544566; PubMed Central PMCID: PMCPMC7293510.
  44. Hu Y, Chen T, Liu M, Zhang L, Wang F, Zhao S, et al. Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct. Acta Ophthalmol. 2020;98:859-63. doi: 10.1111/aos.14456. PubMed PMID: 32406606; PubMed Central PMCID: PMCPMC7272962.
  45. Bischoff WE, Reid T, Russell GB, Peters TR. Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of n95 respirators, surgical masks, and eye protection in humans. J Infect Dis. 2011;204:193-9. doi: 10.1093/infdis/jir238. PubMed PMID: 21673029; PubMed Central PMCID: PMCPMC3164472.
  46. Loffredo L, Pacella F, Pacella E, Tiscione G, Oliva A, Violi F. Conjunctivitis and COVID-19: A meta-analysis. J Med Virol. 2020;92:1413-4. doi: 10.1002/jmv.25938. PubMed PMID: 32330304; PubMed Central PMCID: PMCPMC7264785.
  47. Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138:575-8. doi: 10.1001/jamaophthalmol.2020.1291. PubMed PMID: 32232433; PubMed Central PMCID: PMCPMC7110919.
  48. Liu M, Dai C, Lv X, Li B. Letter to the Editor: Are severe COVID-19 patients more susceptible to conjunctivitis? J Med Virol. 2020;92:2394-5. doi: 10.1002/jmv.26084. PubMed PMID: 32470212; PubMed Central PMCID: PMCPMC7283819.
  49. La Distia Nora R, Putera I, Khalisha DF, Septiana I, Ridwan AS, Sitompul R. Are eyes the windows to COVID-19? Systematic review and meta-analysis. BMJ Open Ophthalmol. 2020;5:e000563. doi: 10.1136/bmjophth-2020-000563. PubMed PMID: 34192152; PubMed Central PMCID: PMCPMC7476422.
  50. Chen L, Yu J, He W, Chen L, Yuan G, Dong F, et al. Risk factors for death in 1859 subjects with COVID-19. Leukemia. 2020;34:2173-83. doi: 10.1038/s41375-020-0911-0. PubMed PMID: 32546725; PubMed Central PMCID: PMCPMC7296516.
  51. Pirraglia MP, Ceccarelli G, Cerini A, Visioli G, d’Ettorre G, Mastroianni CM, et al. Retinal involvement and ocular findings in COVID-19 pneumonia patients. Sci Rep. 2020;10:17419. doi: 10.1038/s41598-020-74446-6. PubMed PMID: 33060700; PubMed Central PMCID: PMCPMC7566835.
  52. Casagrande M, Fitzek A, Puschel K, Aleshcheva G, Schultheiss HP, Berneking L, et al. Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients. Ocul Immunol Inflamm. 2020;28:721-5. doi: 10.1080/09273948.2020.1770301. PubMed PMID: 32469258.
  53. Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R, Jr. Retinal findings in patients with COVID-19. Lancet. 2020;395:1610. doi: 10.1016/S0140-6736(20)31014-X. PubMed PMID: 32405105; PubMed Central PMCID: PMCPMC7217650.
  54. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55-8. doi: 10.1016/j.ijid.2020.03.062. PubMed PMID: 32251791; PubMed Central PMCID: PMCPMC7195378.
  55. Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE, et al. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients. Ophthalmology. 2020;127:977-9. doi: 10.1016/j.ophtha.2020.03.026. PubMed PMID: 32291098; PubMed Central PMCID: PMCPMC7151491.
  56. Ma JX, Wang LN, Zhou RX, Yu Y, Du TX. Real-time polymerase chain reaction for the diagnosis of necrotizing herpes stromal keratitis. Int J Ophthalmol. 2016;9:682-6. doi: 10.18240/ijo.2016.05.07. PubMed PMID: 27275421; PubMed Central PMCID: PMCPMC4886885.
  57. Satpathy G, Mishra AK, Tandon R, Sharma MK, Sharma A, Nayak N, et al. Evaluation of tear samples for Herpes Simplex Virus 1 (HSV) detection in suspected cases of viral keratitis using PCR assay and conventional laboratory diagnostic tools. Br J Ophthalmol. 2011;95:415-8. doi: 10.1136/bjo.2010.191049. PubMed PMID: 20852317.
  58. Bonnin P, Miszczak F, Kin N, Resa C, Dina J, Gouarin S, et al. Study and interest of cellular load in respiratory samples for the optimization of molecular virological diagnosis in clinical practice. BMC Infect Dis. 2016;16:384. doi: 10.1186/s12879-016-1730-9. PubMed PMID: 27503120; PubMed Central PMCID: PMCPMC4977610.
  59. Sun CB, Wang YY, Liu GH, Liu Z. Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know. Front Public Health. 2020;8:155. doi: 10.3389/fpubh.2020.00155. PubMed PMID: 32391309; PubMed Central PMCID: PMCPMC7193031.
  60. Sarma P, Kaur H, Kaur H, Bhattacharyya J, Prajapat M, Shekhar N, et al. Ocular manifestations and tear or conjunctival Swab PCR positivity for 2019-nCoV in Patients with COVID-19: a systematic review and meta-analysis. Available at SSRN 3566161. 2020. doi: 10.2139/ssrn.3566161.
آمار
تعداد مشاهده مقاله: 4,647
تعداد دریافت فایل اصل مقاله: 2,046


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب